42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-1110375
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 4a735c0e-e5c2-473b-9ea3-b69a08544bb2
[Document ID] => 1110375
[Document naam] => FW: SAGE werkgroep over AstraZeneca
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/document/VWS-WOO-08-1110375
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-1110375
[Status] =>
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo
[DocumentPublicationDate] => 11 februari 2021
[DocumentStatusCheckedDate] =>
[DocumentStatusCheckedResult] =>
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 06:09:03
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 06:09:03
)
Document: VWS-WOO-08-1110375
Klik om te vergroten
Document correcties
Geregistreerde datum: 20210211
Geregistreerde documentnaam: FW: SAGE werkgroep over AstraZeneca
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:40:13 |
| Request_Omvang openbaarmaking_documenten | 13.418 | 2025-06-22 23:40:13 |
| Request_Omvang openbaarmaking_paginas | 24.551 | 2025-06-22 23:40:13 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/file/download/inventory | 2025-06-22 23:40:13 |
| document_documentName | FW: SAGE werkgroep over AstraZeneca | 2025-06-22 23:40:13 |
| document_documentType | E-mailbericht | 2025-06-22 23:40:13 |
| document_documentPublicationDate | 2021-02-11 | 2025-06-22 23:40:13 |
| document_documentNumber | VWS-WOO-08-1110375 | 2025-06-22 23:40:13 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:40:13 |
| document_SectionHTMLDataDivs | 3 | 2025-06-22 23:40:13 |
| document_SectionAbout | 1 | 2025-06-22 23:40:13 |
| About_Datum document | 11 februari 2021 | 2025-06-22 23:40:13 |
| About_Type bronbestand | E-mailbericht, 2 pagina's | 2025-06-22 23:40:13 |
| About_Type bronbestand_paginas | 2 | 2025-06-22 23:40:13 |
| About_Download als | PDF (1.3 MB) | 2025-06-22 23:40:13 |
| About_Documentnummer | 1110375 | 2025-06-22 23:40:13 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:40:13 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer buiten verzoek Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkhref_2 | https://wetten.overheid.nl/BWBR0005252/2018-07-28#HoofdstukV | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkname_2 | buiten verzoek | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkhref_3 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over FW: SAGE werkgroep over AstraZeneca (documentnummer 1ee694d4-f88d-65ce-b330-15d4a7a92981) | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkname_3 | Laat het ons weten | 2025-06-22 23:40:13 |
| document_SectionLinked | 1 | 2025-06-22 23:40:13 |
| document_SectionRequest | 1 | 2025-06-22 23:40:13 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode februari 2021 | 2025-06-22 23:40:13 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo | 2025-06-22 23:40:13 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode februari 2021 | 2025-06-22 23:40:13 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 21 december 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode februari 2021. | 2025-06-22 23:40:13 |
| Request_Periode | Februari 2021 | 2025-06-22 23:40:13 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:40:13 |
| Request_Datum besluit | 21 december 2022 | 2025-06-22 23:40:13 |
| Request_Omvang openbaarmaking | 13.418 documenten, 24.551 pagina's Inventarislijst | 2025-06-22 23:40:13 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/file/download/document/1ee694d4-f88d-65ce-b330-15d4a7a92981 | 2025-04-19 22:26:18 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-1110375.pdf | 2025-04-19 22:26:18 |
| DocumentDownload_linkname | Download (pdf, 1.3 MB) | 2025-04-19 22:26:18 |
Archiefversies (7 rijen)
Archiefrij 1 — 2025-10-22 14:09:58
fromFile: VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip
fromFilePath: /volume3/websites/openrijksoverheid/archieven_files/VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip
documentName: VWS-WOO-08-1110375.pdf
documentType: pdf
documentCompressedSize: 1104992
documentSize: 1363322
documentCompressRatio: 81.05143172339329
documentDateModified: 2025-10-09 11:56:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-10-22 14:09:58
lastSeen: 2025-10-22 14:09:58
text: 1110375 pminvws.n]: INEXETSN @minvws.ni] To: Cc: @minvws.nl] From: (EXETIN ) Sent: Thur 2/11/2021 6:11:17 PM Subject: FW: SAGE werkgroep over AstraZeneca Received: Thur 2/11/2021 6:11:18 PM image001.ipg WHO SAGE: Interim recommendations for use of the AZD1222 ...
noTextDate: leeg!
ocrText: Datum: vrijdag 20 augustus 2021 12:16:00 Beste ‚ Eigenlijk zou ik hierover graag een afspraak aan tafel willen. Ik wil graag weten wat de inspectie allemaal doet op dit moment, of dat het hele repertoire is, en of dat echt full force wordt ingezet. Verhalen die de ronde doen (hoor ik uiteraard sl...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 25bce347c9eff6b65641e29a26aadb0a50cf29cf74c432afd921767159b7cc63
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip_2837
textDigestSHA256: d2fd07a57be20ae27693d0e885cf7b8155bceb9eba0e89dd3e167a0be364f8a5
ocrTextDigestSHA256: 0a8c0a926625c74214e56cdceb471d6743facdaf9a019f0c13d9c21860bda4bf
extractedId: VWS-WOO-08-1110375
Archiefrij 2 — 2025-09-07 17:27:46
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1110375.pdf
documentName: VWS-WOO-08-1110375.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 1363322
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:27:46
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:27:46
lastSeen: 2025-09-07 17:27:46
text: 1110375
To: pminvws.n]: INEXETSN(EXETIN@minvws.ni]
Cc: @minvws.nl]
From: )
Sent:Thur 2/11/2021 6:11:17 PM
Subject: FW: SAGE werkgroep over AstraZeneca
Received:Thur 2/11/2021 6:11:18 PM
image001.ipg
WHO SAGE: Interim recommendations foruse oftheAZD1222 (ChAdOx1-S[recombinant]) vaccine against COVID-...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 25bce347c9eff6b65641e29a26aadb0a50cf29cf74c432afd921767159b7cc63
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_54580_803367b0200898e8dce39cb854e81c60
textDigestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1110375
Archiefrij 3 — 2025-09-04 17:04:53
fromFile: VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip
documentName: VWS-WOO-08-1110375.pdf
documentType: pdf
documentCompressedSize: 1104992
documentSize: 1363322
documentCompressRatio: 81.05143172339329
documentDateModified: 2025-05-01 20:39:18
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:04:53
lastSeen: 2025-09-04 17:04:53
text: 1110375
To: pminvws.n]: INEXETSN(EXETIN@minvws.ni]
Cc: @minvws.nl]
From: )
Sent:Thur 2/11/2021 6:11:17 PM
Subject: FW: SAGE werkgroep over AstraZeneca
Received:Thur 2/11/2021 6:11:18 PM
image001.ipg
WHO SAGE: Interim recommendations foruse oftheAZD1222 (ChAdOx1-S[recombinant]) vaccine against COVID-...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 25bce347c9eff6b65641e29a26aadb0a50cf29cf74c432afd921767159b7cc63
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip_2712
textDigestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1110375
Archiefrij 4 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3478791-1040904-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3478791-1040904-pdo.zip
documentName: VWS-WOO-08-1110375-FW_SAGE_werkgroep_over_AstraZeneca_.pdf
documentType: pdf
documentCompressedSize: 1102842
documentSize: 1363322
documentCompressRatio: 80.89372870092319
documentDateModified: 2024-11-19 14:51:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: 1110375
To: pminvws.n]: INEXETSN(EXETIN@minvws.ni]
Cc: @minvws.nl]
From: )
Sent:Thur 2/11/2021 6:11:17 PM
Subject: FW: SAGE werkgroep over AstraZeneca
Received:Thur 2/11/2021 6:11:18 PM
image001.ipg
WHO SAGE: Interim recommendations foruse oftheAZD1222 (ChAdOx1-S[recombinant]) vaccine against COVID-...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 335385
textDigestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1110375
Archiefrij 5 — 2025-02-27 09:25:05
fromFile: 2023.057-VWS-WOO-3478791-1040904-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3478791-1040904-pdo.zip
documentName: VWS-WOO-08-1110375-FW_SAGE_werkgroep_over_AstraZeneca_.pdf
documentType: pdf
documentCompressedSize: 1102842
documentSize: 1363322
documentCompressRatio: 80.89372870092319
documentDateModified: 2024-11-19 14:51:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:05
lastSeen: 2025-02-27 09:25:05
text: 1110375
To: pminvws.n]: INEXETSN(EXETIN@minvws.ni]
Cc: @minvws.nl]
From: )
Sent:Thur 2/11/2021 6:11:17 PM
Subject: FW: SAGE werkgroep over AstraZeneca
Received:Thur 2/11/2021 6:11:18 PM
image001.ipg
WHO SAGE: Interim recommendations foruse oftheAZD1222 (ChAdOx1-S[recombinant]) vaccine against COVID-...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 33, "email": "EXETIN@minvws.ni", "context": "1110375 To: pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From:"}, {"position": 55, "email": "@minvws.nl", "context": "pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From: ) Sent:Thur"}, {"position": 579, "email": "@minvws.nl", "context": "13:22 ) EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW:"}, {"position": 595, "email": "@minvws.nl", "context": ") EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW: SAGE"}]
documentMailAdresses: [{"position": 33, "email": "EXETIN@minvws.ni", "context": "1110375 To: pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From:"}, {"position": 55, "email": "@minvws.nl", "context": "pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From: ) Sent:Thur"}, {"position": 579, "email": "@minvws.nl", "context": "13:22 ) EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW:"}, {"position": 595, "email": "@minvws.nl", "context": ") EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW: SAGE"}]
digestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 248473
textDigestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1110375
Archiefrij 6 — 2025-02-18 12:18:13
fromFile: Besluit__dossier_nr_-6c83ab2d51cf026ac610ece2faff887a7ba1a1fe4e877e2c6b36655c00305357.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-6c83ab2d51cf026ac610ece2faff887a7ba1a1fe4e877e2c6b36655c00305357.zip
documentName: VWS-WOO-08-1110375-FW_SAGE_werkgroep_over_AstraZeneca_.pdf
documentType: pdf
documentCompressedSize: 1102842
documentSize: 1363322
documentCompressRatio: 80.89372870092319
documentDateModified: 2024-11-19 14:51:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1110375
To: pminvws.n]: INEXETSN(EXETIN@minvws.ni]
Cc: @minvws.nl]
From: )
Sent:Thur 2/11/2021 6:11:17 PM
Subject: FW: SAGE werkgroep over AstraZeneca
Received:Thur 2/11/2021 6:11:18 PM
image001.ipg
WHO SAGE: Interim recommendations foruse oftheAZD1222 (ChAdOx1-S[recombinant]) vaccine against COVID-...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 33, "email": "EXETIN@minvws.ni", "context": "1110375 To: pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From:"}, {"position": 55, "email": "@minvws.nl", "context": "pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From: ) Sent:Thur"}, {"position": 579, "email": "@minvws.nl", "context": "13:22 ) EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW:"}, {"position": 595, "email": "@minvws.nl", "context": ") EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW: SAGE"}]
documentMailAdresses: [{"position": 33, "email": "EXETIN@minvws.ni", "context": "1110375 To: pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From:"}, {"position": 55, "email": "@minvws.nl", "context": "pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From: ) Sent:Thur"}, {"position": 579, "email": "@minvws.nl", "context": "13:22 ) EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW:"}, {"position": 595, "email": "@minvws.nl", "context": ") EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW: SAGE"}]
digestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 118097
textDigestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1110375
Archiefrij 7 — 2025-02-18 12:18:00
fromFile: Besluit__dossier_nr_-059f008949175bc5c1c05e6900ee06a7b0f3f1edfa07b5d2ec14c9ecfa5c5bc7.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-059f008949175bc5c1c05e6900ee06a7b0f3f1edfa07b5d2ec14c9ecfa5c5bc7.zip
documentName: VWS-WOO-08-1110375-FW_SAGE_werkgroep_over_AstraZeneca_.pdf
documentType: pdf
documentCompressedSize: 1102842
documentSize: 1363322
documentCompressRatio: 80.89372870092319
documentDateModified: 2024-08-30 08:45:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:00
lastSeen: 2025-02-18 12:18:00
text: 1110375
To: pminvws.n]: INEXETSN(EXETIN@minvws.ni]
Cc: @minvws.nl]
From: )
Sent:Thur 2/11/2021 6:11:17 PM
Subject: FW: SAGE werkgroep over AstraZeneca
Received:Thur 2/11/2021 6:11:18 PM
image001.ipg
WHO SAGE: Interim recommendations foruse oftheAZD1222 (ChAdOx1-S[recombinant]) vaccine against COVID-...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 33, "email": "EXETIN@minvws.ni", "context": "1110375 To: pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From:"}, {"position": 55, "email": "@minvws.nl", "context": "pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From: ) Sent:Thur"}, {"position": 579, "email": "@minvws.nl", "context": "13:22 ) EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW:"}, {"position": 595, "email": "@minvws.nl", "context": ") EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW: SAGE"}]
documentMailAdresses: [{"position": 33, "email": "EXETIN@minvws.ni", "context": "1110375 To: pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From:"}, {"position": 55, "email": "@minvws.nl", "context": "pminvws.n]: INEXETSN(EXETIN@minvws.ni] Cc: @minvws.nl] From: ) Sent:Thur"}, {"position": 579, "email": "@minvws.nl", "context": "13:22 ) EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW:"}, {"position": 595, "email": "@minvws.nl", "context": ") EEE @minvws.nl>;RBB @minvws.nl>;5.1.2e Onderwerp: FW: SAGE"}]
digestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 18960
textDigestSHA256: 40ddd6f137678d9cafa497027e8dab82a4304d7ad7ae4deb73bbdd642ba06aae
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1110375
(dit is ook een speeltuin)